Eastgate Biotech (ETBI) Stock Price & Analysis
ETBI Stock Chart & Stats
- Day’s Range
- $0.01 - $0.01
- 52-Week Range
- $0.01 - $0.01
- Previous Close
- $0.01
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- $11.29M
- Enterprise Value
- $10.67T
- Total Cash (Recent Filing)
- $4,911
- Total Debt (Recent Filing)
- $3.08M
- Price to Earnings (P/E)
- ―
- Beta
- -1439.27
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
ETBI FAQ
What was Eastgate Biotech’s price range in the past 12 months?
What is Eastgate Biotech’s market cap?
When is Eastgate Biotech’s upcoming earnings report date?
Is Eastgate Biotech overvalued?
Does Eastgate Biotech pay dividends?
What is Eastgate Biotech’s EPS estimate?
How many shares outstanding does Eastgate Biotech have?
Which hedge fund is a major shareholder of Eastgate Biotech?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Eastgate Biotech
EastGate Biotech Corp. is a pharmaceutical company specializing in the production and distribution of nutraceuticals. These products are rooted in natural therapies and designed for natural absorption within the body. The firm employs cutting-edge nanotechnologies to provide healthier options compared to conventional pharmaceuticals, which often lead to detrimental side effects and unforeseen issues for individuals seeking to achieve and maintain good health. Among its diverse product line are E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze, and Warts X. EastGate Biotech's development process involves integrating product components into various nano-sized delivery systems. These systems include oil droplets (nanoemulsions), polymeric particles (nanoparticles), and complex combinations of polymers, lipids, and surfactants (such as hybrid nanoparticles, nanocapsules, and mixed micelles). The company has operational bases in prominent cities including New York, London SF, Cockfosters BP, Los Angeles, Chicago, and Las Vegas.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Rosella C. Perri
- Employees
- 2
- Website
- www.EastGateBiotech.com
- Address
- 65 Harbour Square Suite 2203Toronto, M5J 2L4Canada, Toronto, ON, M5J 2L4, CA
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 3 | 2 |
| Technical Analysis | 1 | 1 | 0 |
| Moving Averages | 2 | 2 | 2 |
